← Back to headlines
AgomAb Therapeutics (AGMB) Secures U.S. Patent for AGMB-447
AgomAb Therapeutics (AGMB) has been granted a U.S. patent for its compound AGMB-447.
12 Apr, 18:46 — 12 Apr, 18:46
Sources
Showing 1 of 1 sources
Related Stories
Selena Gomez Sued by Investors for Alleged Fraud in Mental Health Startup
28m ago
Nvidia Discloses $21 Billion Stake in SpaceX and $30 Billion in Intel
38m ago
Consortium Seals $1.9 Billion Investment in Liverpool FC, Amit Bhatia Named Vice-Chairman
40m ago
Berkshire Hathaway Increases Stakes in Alphabet, Delta, and Housing Market
49m ago